Retrolaminar Demyelination of Structurally Intact Axons in Nonhuman Primate Experimental Glaucoma.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure: P. Chaudhary, None; H. Lockwood, None; C. Stowell, None; E. Bushong, None; J. Reynaud, None; H. Yang, None; S.K. Gardiner, None; G. Wiliams, None; I. Williams, None; M. Ellisman, None; N. Marsh-Armstrong, None; C. Burgoyne, Heidelberg Engineering (F, R), Reichert (F)"
"The authors thank their Devers Eye Institute colleagues Brad Fortune and Grant Cull for their assistance with the implementation of the FoBMO sectoral axon count methodology. CB thanks John Crabb, of the Cleveland Clinic, whose preliminary proteomic findings suggested that myelin-related alterations were present in NHP early EG. Supported by NIH R01 EY011610 (CFB), NIH R01 EY029087 (NMA, CFB) American Glaucoma Society (CFB), Sears Trust (CFB), Bright Focus (PC, HY), Alcon Research Institute (PC, CFB), and Legacy Good Samaritan Foundation–Devers Eye Institute Endowment (CFB)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025